Low Cost Standard Therapeutics Opposition, Taf/Ftc, (201817001590)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (3383/DELNP/2005)
Countries: India Date: 2009
-
Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate tenofovir disoproxil fumarate (TDF) , (1135/DEL/2007 (divisional to 896/DEL/2002))
Countries: India Date: 2012
-
Gujarat State Network of People Living with HIV/AIDS opposition, Tenofovir Alafenamide Fumarate , (568/MUMNP/2011)
Countries: India Date: 2015
-
Amrita Majumdar opposition, Tenofovir Alafenamide Fumarate , (568/MUMNP/2011)
Countries: India Date: 2015
-
Intermed Labs opposition, tenofovir disoproxil fumarate (TDF) , (602/DEL/2007 (Divisional from 2076/DEL/1997))
Countries: India Date: 2009
-
Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate (TDF) , (963/DEL/2002 (divisional to 2174/DEL/1998)
Countries: India Date: 2006
-
Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate (TDF) , (2076/DEL/1997)
Countries: India Date: 2006
-
Sahara opposition, tenofovir disoproxil fumarate (TDF) , (2076/DEL/1997)
Countries: India Date: 2008
-
Indian Network of People Living with HIV/AIDS (INP+) and Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate (TDF) , (896/DEL/2002 (divisional from 2174/DEL/1998))
Countries: India Date: 2006
-
Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (9661/DELNP/2007)
Countries: India Date: 2010